Gabapentin No Help for Lingering COVID-Induced Olfactory Dysfunction

(MedPage Today) -- Treatment with oral gabapentin did not improve olfactory dysfunction that remained 3 months after a COVID-19 infection, the randomized GRACE trial showed. Of 44 patients who completed the 8-week fixed-dose phase, 44% of those...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news